Disruptive Mood Dysregulation DisorderNCT01862549
Adapting DBT for Children With DMDD: Pilot RCT
A study testing Dialectical Behavior Therapy for children and Treatment as Usual in people with Disruptive Mood Dysregulation Disorder, run by Weill Medical College of Cornell University at 1 site in United States.
Trial summary
This study examines feasibility and preliminary efficacy of Dialectical Behavior Therapy adapted to children (DBT-C). DBT-C as compared to treatment-as-usual (TAU) is hypothesized to have lower drop-out rate, and higher treatment attendance and satisfaction. Read more about this study
- Who is it for?
- Ages 7 to 12 years
- Conditions the study is for
- Disruptive Mood Dysregulation Disorder
- What is being tested?
- Dialectical Behavior Therapy for children and Treatment as Usual
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 43 participants
- Where
- 1 siteUnited States
- Study dates
- May 2013to Dec 2016
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 7 to 12 years
- All sexes
- No healthy volunteers
- Child
Who may be able to join
- Ages 7 years 0 months to 12 years 11 months
- Meet criteria for Disruptive Mood Dysregulation Disorder on DSM-IV
- Stabilized on psychiatric medication (at least 6 weeks).
- Able to be treated on the outpatient basis
- Children with suicidal ideation, suicidal behavior and non-suicidal self-injury will be included (assessed using Columbia Suicide and Self-Injury Severity Rating Scale) unless other interventions are indicated (e.g., hospitalization, medication).
Who cannot join
- Documented cognitive disability ( if records are not available will use < 85 IQ on Wechsler Intelligence Scale for Children-IV Information and Block Design subtests).
- Current diagnosis of a psychotic disorder (on K-SADS-PL)
- Pervasive Developmental Disorder (on K-SADS-PL)
- Child in the English as Second Language program at school and/or caregivers have language difficulties as per self-report
- Child is in state custody.
- As consistent with DMDD diagnosis, child's co-morbid conditions better account for disruptive mood.
Trial locations and contacts
1 site in 1 country.
United States1 site
Weill Cornell Medical College
White Plains, New York, 10605
About this study
Official title: Adapting Dialectical Behavior Therapy for Children With Disruptive Mood Dysregulation Disorder: Pilot Randomized Clinical Trial
This study examines feasibility and preliminary efficacy of Dialectical Behavior Therapy adapted to children (DBT-C). DBT-C as compared to treatment-as-usual (TAU) is hypothesized to have lower drop-out rate, and higher treatment attendance and satisfaction. Further, DBT-C as compared to TAU will have significantly greater reduction in symptoms of Disruptive Mood Dysregulation disorder, including verbal and behavioral outbursts and angry/irritable mood.
Read the detailed description
Specific Aims:
I: Conduct Pilot Randomized Clinical Trial to evaluate feasibility and efficacy of DBT for children with Disruptive Mood Dysregulation Disorder (DMDD) as compared with Treatment-As-Usual (TAU) (up to 30 children and caregivers in DBT-C and up to 30 children and caregivers in the treatment as usual comparison condition).
Specific Aim 1: Examine feasibility of DBT-C by evaluating the drop-out rates, number of session attended, and treatment satisfaction and any differences in these rates by groups, as well as therapist treatment adherence and competence.
Hypothesis 1: Attendance rate in DBT-C, as compared to TAU, will be at least 10% higher and drop-out rate will be at least 10% lower (primary feasibility endpoint). Further, DBT-C, as compared with TAU will have significantly higher treatment satisfaction rating by subjects (on the child and caregiver Therapy Satisfaction Questionnaires), and by therapists (on Therapist Satisfaction Scale), and higher patient compliance (on Psychosocial Treatment Compliance Scale). Therapist treatment adherence and competence as measured by DBT-C Treatment Integrity Scale, will not fall below 80%.
Specific Aim 2: Examine preliminary efficacy of DBT-C in reducing symptoms of Disruptive Mood Dysregulation Disorder.
Hypothesis 2: Children in DBT-C condition as compared to TAU will have significantly greater reduction in irritability, anger, aggression, temper outbursts, and mood instability (on Clinical Global Impression - Improvement scale [primary categorical outcome] Exploratory Aim 3: Examine efficacy of DBT-C in improving adaptive coping skills, emotional and behavioral regulation, social skills, and reducing aggressive behaviors, affective reactivity, non-suicidal self-harm behaviors, suicidal ideations, suicidal attempts, and non-suicidal self-harm urges.
Hypothesis 3: Children in DBT-C condition as compared to TAU will have significantly greater improvement in adaptive coping skills (on the Children's Coping Strategies Checklist), emotional and behavioral regulation (on the Emotion Regulation Checklist and Child Behavior Checklist - Dysregulation Syndrome) and social skills (on the Social Skills Rating Scale), and significantly greater reduction in aggressive behaviors (Measure of Aggression, Violence and Rage in Children), affective reactivity (on the Affective Reactivity Index and Mood Symptoms Questionnaire). ), and greater reduction in non-suicidal self-harm behaviors (in Columbia Suicide and Self-Injury Severity Rating Scale [C-SSIS] self-injurious behaviors), suicidal ideations (in the C-SSRS suicidal ideation classification category), suicidal attempts (in C-SSIS suicide attempts category), and non-suicidal self-harm urges (in C-SSIS self-injurious urges, no suicidal intent category).
Exploratory Aim 4: Examine efficacy of DBT-C in reducing the need for higher level services.
Hypothesis 4: Children in DBT-C condition as compared to TAU will have significantly fewer psychiatric hospitalization, emergency room visits, total number of days inpatient, and residential care placements (on the Services Assessment Form).
Exploratory Aim 5: Examine whether parent emotion regulation moderate the relationship between intervention and outcomes, while parent ability to effectively cope with children's negative emotions and children's coping skills and emotion regulation mediate outcomes.
Hypothesis 5: Parents' own emotion regulation (on the Difficulties in Emotion Regulation Scale) will moderate outcomes and parents' ability to effectively cope with children's negative emotions (on the Parental Response to Children's Negative Emotions), children coping skills (on the Children's Coping Strategies Checklist) and emotion regulation (on Emotion Regulation Checklist) will mediate outcomes.
- Conditions
- Disruptive Mood Dysregulation Disorder
- Being tested
- Dialectical Behavior Therapy for children, Treatment as Usual
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Dialectical Behavior Therapy for childrenBehavioural
Treatment as UsualBehavioural
| Study group | Role | What they receive |
|---|---|---|
| DBT for children | Experimental | Dialectical Behavior Therapy for children is a 32 session intervention (it consists of 2 pre-treatment sessions and 30 treatment sessions; treatment sessions are to be delivered in 32 weeks total) with once per week meetings, including 30 min. individual child therapy, 20 min. meeting with a caregiver and 40 min. of skills training with both. Receives: Behavioral: Dialectical Behavior Therapy for children |
| Treatment as Usual | Active comparator | Children in active comparison conditions will receive Treatment as Usual (TAU) that primarily consists of 32 weekly sessions of supportive individual psychotherapy and adjunctive family interventions. Individual therapy included cognitive behavioral skills training (e.g., psychoeducation, cognitive modifications, thought blocking) and non-directive supportive therapy. Family therapy includes parenting skills training (e.g., limit setting, reinforcement techniques), structuring household environment, and safety planning. Receives: Behavioral: Treatment as Usual |
What is being measured
The primary outcome is the main question the study is designed to answer.
Attendance and drop-out rate measure
Measured: 32 weeks
Therapy Satisfaction Questionnaire
Measured: 32 weeks
Therapist Satisfaction Questionaire
Measured: 32 weeks
Psychosocial Treatment Compliance Scale
Measured: 32 weeks
Secondary outcomes (12)
Clinical Global Impression Scale
Measured: pre-treatment, 8, 16, 24, 32 weeks, 3-month follow-up
Mood Symptoms Questionnnaire
Measured: pre-treatment, 8, 16, 24, 32 weeks, 3-month follow-up
Children Coping Strategies Checklist
Measured: pre-treatment, 8, 16, 24, 32 weeks, 3-month follow-up
Emotion Regulation Checklist
Measured: pre-treatment, 8, 16, 24, 32 weeks, 3-month follow-up
Child Behavior Checklist
Measured: pre-treatment, 8, 16, 24, 32 weeks, 3-month follow-up
Social Skills Rating Scale
Measured: pre-treatment, 8, 16, 24, 32 weeks, 3-month follow-up
Measure of Aggression, Violence and Rage in Children
Measured: pre-treatment, 8, 16, 24, 32 weeks, 3-month follow-up
Affective Reactivity Index
Measured: pre-treatment, 8, 16, 24, 32 weeks, 3-month follow-up
Columbia Suicide and Self-Injury Serevity Rating Scale
Measured: pre-treatment, 8, 16, 24, 32 weeks, 3-month follow-up
Services Assessment Form
Measured: pre-treatment, 8, 16, 24, 32 weeks, 3-month follow-up
Difficulties in Emotion Regulation Scale
Measured: pre-treatment, 8, 16, 24, 32 weeks, 3-month follow-up
Parental Response to Children's Negative Emotions Scale
Measured: pre-treatment, 8, 16, 24, 32 weeks, 3-month follow-up
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted24 May 2013 (estimated)
- Study startMay 2013
- Primary completionDec 2015
- Study completionDec 2016
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (1)Papers the sponsor has linked to this study.
- Other trials for Disruptive Mood Dysregulation DisorderStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind
- Who is masked
- Outcomes assessor
- Enrolment
- 43 participants (actual)
Sponsor and investigators
- Lead sponsor
- Weill Medical College of Cornell University
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
- Investigators
- Francheska Perepletchikova, PhD, Principal investigator, Weill Medical College of Cornell University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT01862549
- Sponsor's protocol ID
- 1205012350
- Status last verified
- Feb 2019
- First submitted
- 20 May 2013
- Last updated
- 1 Mar 2019
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
Publications
Perepletchikova F, Nathanson D, Axelrod SR, Merrill C, Walker A, Grossman M, Rebeta J, Scahill L, Kaufman J, Flye B, Mauer E, Walkup J. Randomized Clinical Trial of Dialectical Behavior Therapy for Preadolescent Children With Disruptive Mood Dysregulation Disorder: Feasibility and Outcomes. J Am Acad Child Adolesc Psychiatry. 2017 Oct;56(10):832-840. doi: 10.1016/j.jaac.2017.07.789. Epub 2017 Aug 10.
PubMed 28942805
Study at a glance
From the registry record, last updated by the sponsor on 1 Mar 2019. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Adapting Dialectical Behavior Therapy for Children With Disruptive Mood Dysregulation Disorder: Pilot Randomized Clinical Trial
- ClinicalTrials.gov ID
- NCT01862549
- Acronym / sponsor ID
- 1205012350
- Conditions
- Disruptive Mood Dysregulation Disorder
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 43 participants (actual)
- Lead sponsor
- Weill Medical College of Cornell UniversityUniversity, hospital or other
- Study start
- May 2013
- Primary completion
- Dec 2015 (actual)
- Study completion
- Dec 2016 (actual)
- First posted
- 24 May 2013 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This study examines feasibility and preliminary efficacy of Dialectical Behavior Therapy adapted to children (DBT-C). DBT-C as compared to treatment-as-usual (TAU) is hypothesized to have lower drop-out rate, and higher treatment attendance and satisfaction. Further, DBT-C as compared to TAU will have significantly greater reduction in symptoms of Disruptive Mood Dysregulation disorder, including verbal and behavioral outbursts and angry/irritable mood.
Detailed description
Specific Aims:
I: Conduct Pilot Randomized Clinical Trial to evaluate feasibility and efficacy of DBT for children with Disruptive Mood Dysregulation Disorder (DMDD) as compared with Treatment-As-Usual (TAU) (up to 30 children and caregivers in DBT-C and up to 30 children and caregivers in the treatment as usual comparison condition).
Specific Aim 1: Examine feasibility of DBT-C by evaluating the drop-out rates, number of session attended, and treatment satisfaction and any differences in these rates by groups, as well as therapist treatment adherence and competence.
Hypothesis 1: Attendance rate in DBT-C, as compared to TAU, will be at least 10% higher and drop-out rate will be at least 10% lower (primary feasibility endpoint). Further, DBT-C, as compared with TAU will have significantly higher treatment satisfaction rating by subjects (on the child and caregiver Therapy Satisfaction Questionnaires), and by therapists (on Therapist Satisfaction Scale), and higher patient compliance (on Psychosocial Treatment Compliance Scale). Therapist treatment adherence and competence as measured by DBT-C Treatment Integrity Scale, will not fall below 80%.
Specific Aim 2: Examine preliminary efficacy of DBT-C in reducing symptoms of Disruptive Mood Dysregulation Disorder.
Hypothesis 2: Children in DBT-C condition as compared to TAU will have significantly greater reduction in irritability, anger, aggression, temper outbursts, and mood instability (on Clinical Global Impression - Improvement scale [primary categorical outcome] Exploratory Aim 3: Examine efficacy of DBT-C in improving adaptive coping skills, emotional and behavioral regulation, social skills, and reducing aggressive behaviors, affective reactivity, non-suicidal self-harm behaviors, suicidal ideations, suicidal attempts, and non-suicidal self-harm urges.
Hypothesis 3: Children in DBT-C condition as compared to TAU will have significantly greater improvement in adaptive coping skills (on the Children's Coping Strategies Checklist), emotional and behavioral regulation (on the Emotion Regulation Checklist and Child Behavior Checklist - Dysregulation Syndrome) and social skills (on the Social Skills Rating Scale), and significantly greater reduction in aggressive behaviors (Measure of Aggression, Violence and Rage in Children), affective reactivity (on the Affective Reactivity Index and Mood Symptoms Questionnaire). ), and greater reduction in non-suicidal self-harm behaviors (in Columbia Suicide and Self-Injury Severity Rating Scale [C-SSIS] self-injurious behaviors), suicidal ideations (in the C-SSRS suicidal ideation classification category), suicidal attempts (in C-SSIS suicide attempts category), and non-suicidal self-harm urges (in C-SSIS self-injurious urges, no suicidal intent category).
Exploratory Aim 4: Examine efficacy of DBT-C in reducing the need for higher level services.
Hypothesis 4: Children in DBT-C condition as compared to TAU will have significantly fewer psychiatric hospitalization, emergency room visits, total number of days inpatient, and residential care placements (on the Services Assessment Form).
Exploratory Aim 5: Examine whether parent emotion regulation moderate the relationship between intervention and outcomes, while parent ability to effectively cope with children's negative emotions and children's coping skills and emotion regulation mediate outcomes.
Hypothesis 5: Parents' own emotion regulation (on the Difficulties in Emotion Regulation Scale) will moderate outcomes and parents' ability to effectively cope with children's negative emotions (on the Parental Response to Children's Negative Emotions), children coping skills (on the Children's Coping Strategies Checklist) and emotion regulation (on Emotion Regulation Checklist) will mediate outcomes.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind (outcomes assessor)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| DBT for children | Experimental | Behavioral: Dialectical Behavior Therapy for childrenDialectical Behavior Therapy for children is a 32 session intervention (it consists of 2 pre-treatment sessions and 30 treatment sessions; treatment sessions are to be delivered in 32 weeks total) with once per week meetings, including 30 min. individual child therapy, 20 min. meeting with a caregiver and 40 min. of skills training with both. |
| Treatment as Usual | Active comparator | Behavioral: Treatment as UsualChildren in active comparison conditions will receive Treatment as Usual (TAU) that primarily consists of 32 weekly sessions of supportive individual psychotherapy and adjunctive family interventions. Individual therapy included cognitive behavioral skills training (e.g., psychoeducation, cognitive modifications, thought blocking) and non-directive supportive therapy. Family therapy includes parenting skills training (e.g., limit setting, reinforcement techniques), structuring household environment, and safety planning. |
Who may qualify
- Ages
- 7 to 12 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Child
Key inclusion criteria (5 listed)
- Ages 7 years 0 months to 12 years 11 months
- Meet criteria for Disruptive Mood Dysregulation Disorder on DSM-IV
- Stabilized on psychiatric medication (at least 6 weeks).
- Able to be treated on the outpatient basis
- Children with suicidal ideation, suicidal behavior and non-suicidal self-injury will be included (assessed using Columbia Suicide and Self-Injury Severity Rating Scale) unless other interventions are indicated (e.g., hospitalization, medication).
Key exclusion criteria (6 listed)
- Documented cognitive disability ( if records are not available will use < 85 IQ on Wechsler Intelligence Scale for Children-IV Information and Block Design subtests).
- Current diagnosis of a psychotic disorder (on K-SADS-PL)
- Pervasive Developmental Disorder (on K-SADS-PL)
- Child in the English as Second Language program at school and/or caregivers have language difficulties as per self-report
- Child is in state custody.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Dialectical Behavior Therapy for children | Behavioural | DBT for children |
| Treatment as Usual | Behavioural | Treatment as Usual |
Primary outcome
Attendance and drop-out rate measure
Time frame: 32 weeks
Therapy Satisfaction Questionnaire
Time frame: 32 weeks
Therapist Satisfaction Questionaire
Time frame: 32 weeks
Psychosocial Treatment Compliance Scale
Time frame: 32 weeks
12 secondary outcomes
Clinical Global Impression Scale
Time frame: pre-treatment, 8, 16, 24, 32 weeks, 3-month follow-up
Mood Symptoms Questionnnaire
Time frame: pre-treatment, 8, 16, 24, 32 weeks, 3-month follow-up
Children Coping Strategies Checklist
Time frame: pre-treatment, 8, 16, 24, 32 weeks, 3-month follow-up
Emotion Regulation Checklist
Time frame: pre-treatment, 8, 16, 24, 32 weeks, 3-month follow-up
Child Behavior Checklist
Time frame: pre-treatment, 8, 16, 24, 32 weeks, 3-month follow-up
Social Skills Rating Scale
Time frame: pre-treatment, 8, 16, 24, 32 weeks, 3-month follow-up
Measure of Aggression, Violence and Rage in Children
Time frame: pre-treatment, 8, 16, 24, 32 weeks, 3-month follow-up
Affective Reactivity Index
Time frame: pre-treatment, 8, 16, 24, 32 weeks, 3-month follow-up
Columbia Suicide and Self-Injury Serevity Rating Scale
Time frame: pre-treatment, 8, 16, 24, 32 weeks, 3-month follow-up
Services Assessment Form
Time frame: pre-treatment, 8, 16, 24, 32 weeks, 3-month follow-up
Difficulties in Emotion Regulation Scale
Time frame: pre-treatment, 8, 16, 24, 32 weeks, 3-month follow-up
Parental Response to Children's Negative Emotions Scale
Time frame: pre-treatment, 8, 16, 24, 32 weeks, 3-month follow-up
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 1 Mar 2019.
- Derived from this study: PubMed 28942805Perepletchikova F, Nathanson D, Axelrod SR, Merrill C, Walker A, Grossman M, Rebeta J, Scahill L, Kaufman J, Flye B, Mauer E, Walkup J. Randomized Clinical Trial of Dialectical Behavior Therapy for Preadolescent Children With Disruptive Mood Dysregulation Disorder: Feasibility and Outcomes. J Am Acad Child Adolesc Psychiatry. 2017 Oct;56(10):832-840. doi: 10.1016/j.jaac.2017.07.789. Epub 2017 Aug 10.
- NCBI LinkLink provided by the sponsor.
Related trials for Disruptive Mood Dysregulation Disorder
RecruitingObservational study
Psychotherapy for Irritability in Youth: Comparing Active Treatment to Nonactive Psychoeducation Supportive Psychotherapy
Irritability, Disruptive Mood Dysregulation Disorder
RecruitingObservational study
Studies of Brain Function and Course of Illness in Pediatric Bipolar Disorder
Mood Disorder
Recruiting
Neurostimulation Versus Therapy for Problems With Emotions
Emotion Regulation, Mood Disorders
RecruitingObservational study
Focus Groups in Ethnically and Racially Diverse Families
Attention Deficit/Hyperactivity Disorder, Emotional Dysfunction
Recruiting
Optimizing Research With Diverse Families - Feasibility and Acceptability Study (FAST)
Attention Deficit/Hyperactivity Disorder, Emotional Dysfunction
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Francheska Perepletchikova, PhD principal investigator
Weill Medical College of Cornell University
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Dialectical Behavior Therapy for children and Treatment as Usual in people with Disruptive Mood Dysregulation Disorder, run by Weill Medical College of Cornell University at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 5 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 1 Mar 2019. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Attendance and drop-out rate measure (time frame: 32 weeks). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT01862549, which also lists 1 linked publication.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 1 Mar 2019.